So beautiful...Her voice is coming from another world..💖💖 🌹Aida Garifullina - Ave Maria (Schubert)

Tratamientos secuenciales usados en el manejo de la osteoporosis. Approach to the Patient - Transitions in Osteoporosis Therapy. 📚 The Journal of Clinical Endocrinology & Metabolism - 2025. doi: doi.org/10.1210/clinem…

Gracias truco… Por qué no lo supe antes?!

🚨 Si tu Gmail se ha quedado sin espacio, esto te va a salvar. Cuando alcanzas el límite, Gmail deja de funcionar con normalidad. Te explico cómo liberar espacio paso a paso 👇

A proposed mechanism for statin-induced Type 2 Diabetes (T2D). frontiersin.org/journals/endoc…

🙌We are pleased to share our latest publication: “Inhibition of ANGPTL3 as a target for managing hypertriglyceridemia” recently published in Current Opinion in Endocrinology, Diabetes and Obesity. 👉Scope: Comprehensive review of ANGPTL3 inhibition as a therapeutic

"Mancuernas" Porque está es la forma correcta de hacer un entrenamiento completo con mancuernas. Y vos seguro lo estabas haciendo como el orto en el gimnasio, empezá a hacerlo bien, pedazo de pelotudo.

¿Alguien me podría recomendar una aplicación de inteligencia artificial para estudiar inglés?

👉Pharmacotherapy development and trends in lipidology: An expert discussion ☝️Key takeaways 1️⃣ ASCVD prevention remains lipid-centric: Lowering atherogenic lipoproteins—especially LDL-C—continues to be the cornerstone of cardiovascular risk reduction, but it is no longer

💊🫀 Lipidology in 2025: from “lower LDL” to precision prevention This expert discussion in the Journal of Clinical Lipidology (2025) offers a rare, insider view on how lipid-lowering drugs are actually conceived, developed, and translated into practice—and where the field is

Everyone with an interest in Lipoprotein (a) should follow this new (2025) Open Access Journal totally devoted to Lp(a) and entitled Advances in Lipoprotein(a) Research Advances in Lipoprotein(a) Research-ALR There are some great papers including this fantastic review sciexplor.com/articles/alr.2…

Our #MostRead article in 2025: Definition and diagnostic criteria of #clinical #obesity thelancet.com/journals/landi… #FREE to read with registration (also FREE)

Liver fibrosis + hyperinsulinemia are central drivers of bad outcomes in MASLD/MASH. The MASLD pathway → liver fibrosis + impaired hepatic insulin clearance → worsening insulin resistance + hyperinsulinemia (an independent predictor of MACE). Liver fibrosis also ↑ portal

Vitamin A modulates obesity biology. Carotenoids reduce inflammation, influence adipogenesis and adipocyte “browning,” and affect brain‑regulated feeding behavior. nature.com/articles/s4136…

Dapagliflozin was associated with a significant reduction in liver fat independent of weight loss. onlinelibrary.wiley.com/doi/10.1002/ob…

🧐

minervamedica.it/en/journals/mi…

Thyroid hormone conversion is the peripheral process where T4 is converted into T3. To ensure optimal treatment of hypothyroidism, it is important to understand thyroid physiology and thoroughly evaluate thyroid dysfunction.